Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-α

Oncology Reports

Volumn 10, Issue 3, 2003, Pages 537-543

  Zhaorigetu, Siqin ^a   Yanaka, Noriyuki ^a   Sasaki, Masahiro ^b   Watanabe, Hiromitsu ^a   Kato, Norihisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Seiren Co Ltd   (Japan)

Author keywords

Inflammatory response; Oxidative stress; Sericin; Skin tumorigenesis; TNF

Indexed keywords

4 HYDROXYNONENAL; 4-HYDROXY-2-NONENAL; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ALDEHYDE; ANTINEOPLASTIC AGENT; CARCINOGEN; CYCLOOXYGENASE 2; CYCLOPEPTIDE; ISOENZYME; MONOPHENOL MONOOXYGENASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN SYNTHASE; SERICIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; EPIDERMIS; FEMALE; HYPERPLASIA; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; ONCOGENE; ONCOGENE MYC; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; SKIN; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ALDEHYDES; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CYCLOOXYGENASE 2; EPIDERMIS; FEMALE; GENES, FOS; GENES, MYC; HYPERPLASIA; INFLAMMATION; ISOENZYMES; MICE; MICE, INBRED ICR; MONOPHENOL MONOOXYGENASE; OXIDATIVE STRESS; PEPTIDES, CYCLIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SERICINS; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0142031886     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Voegeli R, Meier J and Blust R: Sericin silk protein: unique structure and properties. Cosmetics Toiletries 108: 101-108, 1993.
2. Kato N, Sato S, Yamanaka J, Yamada H, Fuwa N and Nomura M: Silk protein, sericin inhibits lipid peroxidation and tyrosinase activity. Biosci Biotechnol Biochem 62: 145-147, 1998.
3. Sasaki M, Kato N, Watanabe H and Yamada H: Silk protein, sericin, suppresses colon carcinogenesis induced by 1,2-dimethylhydrazine in mice. Oncology Rep 7: 1049-1052, 2000.
4. Zhaorigetu S, Sasaki M, Watanabe H and Kato N: Supplemental silk protein, sericin, suppresses colon tumorigenesis in 1,2-dimethylhydrazine-treated mice by reducing oxidative stress and cell proliferation. Biosci Biotechnol Biochem 65: 2181-2186, 2001. (Pubitemid 33617187)
5. Lahiri M, Mukhtar H and Agarwal R: Reactive intermediates and skin cancer. In: Carcinogenicity: Testing, Predicting and Interpreting Chemical Effects. Kitchin KT (ed). Marcel Dekker, New York, pp679-714, 1999.
6. Ames BN, Gold LS and Willett WC: The causes and prevention of cancer. Proc Natl Acad Sci USA 92: 5258-5265, 1995.
7. Garmyn M and Degreef H: Suppression of UVB-induced c-fos and c-jun repression in human keratinocytes by N-acetylcysteine. J Photochem Photobio B37: 125-130, 1997. (Pubitemid 27068145)
8. Dragsted LO: Natural antioxidants in chemoprevention. Arch Toxicol Suppl 20: 209-226, 1998.
9. Nakamura Y, Murakami A, Ohto Y, Torikai K, Tanaka T and Ohigashi H: Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1′-acetoxychavicol acetate. Cancer Res 58: 4832-4839, 1998. (Pubitemid 28503678)
10. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E and Fujiki H: Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 59: 4516-4518, 1999. (Pubitemid 29428949)
11. Fujiki H, Sueoka E, Komori A and Suganuma M: Tumor promotion and TNF-α gene expression by the okadaic acid class tumor promoters. Environ Carcino Ecotox Revs 15: 1-40, 1997. (Pubitemid 27225133)
12. Komatsu S, Watanabe H, Oka T, Tsuge H, Nii H and Kato N: Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 131: 2204-2207, 2001. (Pubitemid 32720653)
13. Murakami A, Nakamura Y, Torikai K, et al: Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60: 5059-5066, 2000.
14. Skarin T, Rozell BL, Bergman J, Toftgard R and Möller L: Protection against 12-o-tetradecanoylphorbol 13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6 (2-dimethylaminoethyl)-6H-indolo-[2,3-b] quinoxaline analogue of ellipticine. Chem Biol Interact 122: 89-106, 1999. (Pubitemid 29414813)
15. Lahiri-Chatterjee M, Katiyar SK, Mohan RR and Agarwal R: A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res 59: 622-632, 1999. (Pubitemid 29076060)
16. Kim J and Shine DM: Biomarkers of squamous cell carcinoma of the head and neck. Histol Histopathol 12: 205-218, 1997. (Pubitemid 27106932)
17. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK and Hittelman WN: Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst 85: 971-978, 1993. (Pubitemid 23177583)
18. Zhao J, Sharma Y and Agarwal R: Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenease-2 and interleukin-1α expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion. Mol Carcinog 26: 321-333, 1999.
19. Esterbauer H, Schaur RJ and Zollnner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radie Biol Med 11: 81-128, 1991. (Pubitemid 121003917)
20. Zhao YF, Xue Y, Oberley TD, et al: Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 61: 6082-6088, 2001. (Pubitemid 32762543)
21. Yuen MF, Wu PC, Lai VC, Lau JY and Lai CL: Expression of c-myc, c-fos, and c-jun in hepatocellular carcinoma. Cancer 91: 106-112,2001. (Pubitemid 32052620)
22. Nose K, Shibanuma M, Kikuchi K, Kageyama H, Sakiyama S and Kuroki T: Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur J Biochem 201: 99-106, 1991.
23. Shibanuma M, Kuroki T and Nose K: Induction of DNA replication and expression of proto-oncogene c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene3: 17-21,1988.
24. Frenkel K: Oxidation of DNA bases by tumor promoter-activated processes. Environ Health Perspect 81: 45-54, 1986.
25. Witz G: Active oxygen species as factors in multistage carcinogenesis. Proc Soc Exp Biol Med 52: 3952-3960, 1991.
26. Kim J, Yook JI, Park KK, et al: Anti-promotion effect of chlorophyllin in DMBA-TPA-induced mouse skin carcinogenesis. Anticancer Res 20: 1493-1498, 2000. (Pubitemid 30628155)
27. Nanji AN, Miao LM, Thomas O, et al: Enhanced cyclooxygenease-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112: 943-951, 1997.
28. Kumagai T, Kawamoto Y, Nakamura Y, Hatayama I, Satoh K, Osawa T and Uchida K: 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 273: 437-441, 2000. (Pubitemid 30599004)
29. Muller DK, Kopp SA, Marks F, Seibert K and Furstenberger G: Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2. Mol Carcinog 23: 36-44, 1998. (Pubitemid 28441058)
30. Marks F, Furstenberger G and Muller-Decker K: Arachidonic acid metabolism as a reporter of skin irritancy and target of cancer chemoprevention. Toxicol Lett 97: 111-118, 1998. (Pubitemid 28430304)
31. Robertson FM, Ross MS, Tober KL, Long BW and Oberyszyn TM: Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. Carcinogenesis 17: 1719-1728, 1996. (Pubitemid 26280398)
32. Marino MW, Dianne-Grail AD, Inglese M, et al: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94: 8093-8098, 1997. (Pubitemid 27343782)
33. Komori A, Yatsunami J, Suganuma M, et al: Tumor necrosis factor acts as a tumor prometer in BALB/3T3 cell transformation. Cancer Res 53: 1982-1985, 1993. (Pubitemid 23145713)
34. Arnott CH, Scott KA, Moore RJ, et al: Tumor necrosis factor-α mediates tumor promotion via a PKCα- and AP-1-dependent pathway. Oncogene 21: 4728-4738, 2002. (Pubitemid 34879448)
35. Moore RJ, Owens DM, Stamp G, et al: Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 5: 828-831, 1999. (Pubitemid 29318619)